BeOne Medicines AG
ONC
$316.99
-$5.38-1.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.73% | 32.36% | 7,326.77% | 100.84% | -25.16% |
| Total Depreciation and Amortization | -3.66% | 19.70% | -5.58% | -35.53% | -30.02% |
| Total Amortization of Deferred Charges | 968.12% | -73.26% | 390.11% | -0.85% | -0.25% |
| Total Other Non-Cash Items | -2.83% | 9.43% | 45.75% | -55.01% | 81.23% |
| Change in Net Operating Assets | 63.52% | 1,768.48% | 106.86% | -313.67% | -114.46% |
| Cash from Operations | 3.68% | 52.71% | 497.97% | -41.35% | -60.10% |
| Capital Expenditure | 21.97% | -9.72% | 22.30% | 39.01% | 30.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.68% | 94.78% | 65.24% | -5,725.24% | -395.59% |
| Cash from Investing | 22.20% | 26.02% | 45.38% | -30.27% | 30.08% |
| Total Debt Issued | -- | -100.00% | 76.90% | -85.29% | -- |
| Total Debt Repaid | -18,281.82% | 96.31% | 34.83% | 68.21% | -15,546.62% |
| Issuance of Common Stock | -76.11% | 142.99% | -47.69% | 620.40% | -45.79% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.16% | -- | -- | -- | -- |
| Cash from Financing | -89.92% | 2,644.53% | 203.69% | -646.78% | -135.72% |
| Foreign Exchange rate Adjustments | 133.84% | -57.81% | 574.63% | 106.73% | -282.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.32% | 418.39% | 336.23% | -44.82% | -178.20% |